ArticleLeukemia2019
The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies.
Sven Christian et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
132 papers cite itlatest 60 shown
this papercites it